April 20, 2021

A Corporate M&A Series: Your Next Deal Will Be Different - Part 2

As the COVID-19 pandemic spread across the globe in early 2020, its impact on M&A volume was immediate. M&A activity rebounded with announced volumes for the 4th quarter of 2020 exceeding 2019 levels. Still, the pandemic recalibrated the ways in which buyers and sellers analyze and value targets.

In the second installment of A&M’s Your Next Deal Will Be Different series, we examine common COVID-19 adjustments that buyers and sellers are making to EBITDA, trends in valuation and forecasts, and trends in contingent consideration provisions.

 

Read the Other Reports in this Series:
In the fourth installment of A&M’s Your Next Deal Will Be Different series, we examine talent strategy and retention during the Great Resignation.
In the third installment of A&M’s Your Next Deal Will Be Different series, we examine ways in which a company can leverage ESG tactics to mitigate risks and add value to their M&A transactions.
The pandemic has significantly impacted M&A activity. In stark contrast
to the historic highs seen globally over the past five years, the economic
uncertainty created by it essentially paused transactions in the
market in early spring of 2020.
Authors

Thomas Bresnahan

Director
FOLLOW & CONNECT WITH A&M